Goldman Sachs' (GS) Goldman Sachs Asset Management unit, Blackstone (BX) and Apollo Global Management (APO) are set to provide a roughly 1.4 billion Australian dollars ($976.2 million) loan to back BGH Capital's acquisition of Aspen Pharmacare's Asia Pacific operations, Bloomberg reported Thursday, citing people familiar with the matter.

BGH Capital said in December it agreed to buy the Asia Pacific businesses of the drugmaker for 2.37 billion Australian dollars, according to the report.

The loan is expected to be covenant-lite, with leverage of about 6.5 times earnings and pricing at roughly 475 basis points over the Bank Bill Swap Bid Rate, the report said citing a source.

Goldman Sachs Asset Management, Blackstone and Apollo Global Management did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)